Ken-ichi Mabuchi

Title: Ken-ichi Mabuchi: Innovator in Pharmaceutical Compositions

Introduction

Ken-ichi Mabuchi is a notable inventor based in Osaka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative work on isoquinoline derivatives. His research has led to advancements in the development of medications that target specific health conditions.

Latest Patents

Mabuchi holds a patent for "Pharmaceutical compositions containing isoquinoline derivatives." This patent describes pharmaceutical compositions that exhibit excellent inhibitory action on an isozyme of phosphodiesterase type IV (PDEIV). The active component of this composition is an isoquinoline derivative, which is represented by a specific general formula. These isoquinoline derivatives are highly specific to PDEIV and are useful as pharmaceuticals, including antidepressive agents, tranquilizers, antidemential agents, anti-inflammatory agents, antiallergic agents, antiasthmatic agents, liver-protecting agents, and diuretic agents. He has 1 patent to his name.

Career Highlights

Ken-ichi Mabuchi is associated with Nippon Zoki Pharmaceutical Co., Ltd., where he has been instrumental in advancing pharmaceutical research. His work has contributed to the development of effective treatments for various medical conditions, showcasing his dedication to improving healthcare through innovation.

Collaborations

Mabuchi has collaborated with notable colleagues, including Shoichi Imai and Minoru Kawamura. These partnerships have fostered a collaborative environment that enhances the research and development of new pharmaceutical solutions.

Conclusion

Ken-ichi Mabuchi's contributions to the field of pharmaceuticals, particularly through his patent on isoquinoline derivatives, highlight his role as an innovator in the industry. His work continues to impact the development of effective medications for various health conditions.